nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.0532	0.0767	CcSEcCtD
Propericiazine—Cardiac fibrillation—Lisinopril—dilated cardiomyopathy	0.046	0.0664	CcSEcCtD
Propericiazine—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.0335	0.0484	CcSEcCtD
Propericiazine—Moricizine—SCN5A—dilated cardiomyopathy	0.0291	0.641	CrCbGaD
Propericiazine—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.0263	0.038	CcSEcCtD
Propericiazine—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.0187	0.027	CcSEcCtD
Propericiazine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0183	0.0264	CcSEcCtD
Propericiazine—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.0182	0.0263	CcSEcCtD
Propericiazine—ADRA1B—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.0171	0.0655	CbGpPWpGaD
Propericiazine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.017	0.0245	CcSEcCtD
Propericiazine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0165	0.0238	CcSEcCtD
Propericiazine—Trifluoperazine—TNNC1—dilated cardiomyopathy	0.0163	0.359	CrCbGaD
Propericiazine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0154	0.0222	CcSEcCtD
Propericiazine—ADRA2A—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.0141	0.054	CbGpPWpGaD
Propericiazine—ADRA1B—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.0139	0.053	CbGpPWpGaD
Propericiazine—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.0137	0.0197	CcSEcCtD
Propericiazine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.0132	0.0191	CcSEcCtD
Propericiazine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.012	0.0173	CcSEcCtD
Propericiazine—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.012	0.0173	CcSEcCtD
Propericiazine—ADRA2A—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.0115	0.0438	CbGpPWpGaD
Propericiazine—Confusional state—Spironolactone—dilated cardiomyopathy	0.0106	0.0153	CcSEcCtD
Propericiazine—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.0106	0.0153	CcSEcCtD
Propericiazine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00995	0.0144	CcSEcCtD
Propericiazine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00994	0.0143	CcSEcCtD
Propericiazine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00958	0.0138	CcSEcCtD
Propericiazine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00934	0.0135	CcSEcCtD
Propericiazine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00917	0.0132	CcSEcCtD
Propericiazine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00907	0.0131	CcSEcCtD
Propericiazine—Drowsiness—Furosemide—dilated cardiomyopathy	0.00896	0.0129	CcSEcCtD
Propericiazine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00836	0.0121	CcSEcCtD
Propericiazine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0083	0.012	CcSEcCtD
Propericiazine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00774	0.0112	CcSEcCtD
Propericiazine—Asthma—Lisinopril—dilated cardiomyopathy	0.00754	0.0109	CcSEcCtD
Propericiazine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00747	0.0108	CcSEcCtD
Propericiazine—DRD1—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0074	0.0283	CbGpPWpGaD
Propericiazine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00735	0.0106	CcSEcCtD
Propericiazine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00719	0.0104	CcSEcCtD
Propericiazine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00719	0.0104	CcSEcCtD
Propericiazine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00694	0.01	CcSEcCtD
Propericiazine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00688	0.00993	CcSEcCtD
Propericiazine—Weight increased—Lisinopril—dilated cardiomyopathy	0.00686	0.0099	CcSEcCtD
Propericiazine—DRD1—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.00682	0.0261	CbGpPWpGaD
Propericiazine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.0068	0.00981	CcSEcCtD
Propericiazine—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00676	0.00976	CcSEcCtD
Propericiazine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00668	0.00964	CcSEcCtD
Propericiazine—Rash—Spironolactone—dilated cardiomyopathy	0.00662	0.00956	CcSEcCtD
Propericiazine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00662	0.00955	CcSEcCtD
Propericiazine—Vision blurred—Furosemide—dilated cardiomyopathy	0.0066	0.00952	CcSEcCtD
Propericiazine—Jaundice—Lisinopril—dilated cardiomyopathy	0.00655	0.00946	CcSEcCtD
Propericiazine—Agitation—Furosemide—dilated cardiomyopathy	0.00644	0.00929	CcSEcCtD
Propericiazine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00627	0.00905	CcSEcCtD
Propericiazine—Nausea—Spironolactone—dilated cardiomyopathy	0.00624	0.009	CcSEcCtD
Propericiazine—DRD1—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00622	0.0238	CbGpPWpGaD
Propericiazine—ADRA1B—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00606	0.0232	CbGpPWpGaD
Propericiazine—DRD1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00599	0.0229	CbGpPWpGaD
Propericiazine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00583	0.00841	CcSEcCtD
Propericiazine—Confusional state—Furosemide—dilated cardiomyopathy	0.00576	0.00831	CcSEcCtD
Propericiazine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00552	0.00797	CcSEcCtD
Propericiazine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00539	0.00778	CcSEcCtD
Propericiazine—Hypotension—Furosemide—dilated cardiomyopathy	0.00534	0.00771	CcSEcCtD
Propericiazine—ADRA1B—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00509	0.0195	CbGpPWpGaD
Propericiazine—Somnolence—Furosemide—dilated cardiomyopathy	0.00508	0.00733	CcSEcCtD
Propericiazine—DRD1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00504	0.0193	CbGpPWpGaD
Propericiazine—ADRA2A—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.005	0.0191	CbGpPWpGaD
Propericiazine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00495	0.00714	CcSEcCtD
Propericiazine—Tremor—Lisinopril—dilated cardiomyopathy	0.00492	0.0071	CcSEcCtD
Propericiazine—ADRA1B—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00491	0.0188	CbGpPWpGaD
Propericiazine—Constipation—Furosemide—dilated cardiomyopathy	0.00489	0.00705	CcSEcCtD
Propericiazine—Angioedema—Lisinopril—dilated cardiomyopathy	0.0048	0.00693	CcSEcCtD
Propericiazine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00452	0.00652	CcSEcCtD
Propericiazine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00437	0.00631	CcSEcCtD
Propericiazine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00432	0.00624	CcSEcCtD
Propericiazine—Oedema—Lisinopril—dilated cardiomyopathy	0.00429	0.00619	CcSEcCtD
Propericiazine—Infection—Lisinopril—dilated cardiomyopathy	0.00426	0.00615	CcSEcCtD
Propericiazine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00421	0.00608	CcSEcCtD
Propericiazine—ADRA2A—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0042	0.0161	CbGpPWpGaD
Propericiazine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00419	0.00604	CcSEcCtD
Propericiazine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00415	0.00598	CcSEcCtD
Propericiazine—ADRA1B—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00413	0.0158	CbGpPWpGaD
Propericiazine—ADRA2A—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00405	0.0155	CbGpPWpGaD
Propericiazine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00401	0.00578	CcSEcCtD
Propericiazine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00391	0.00564	CcSEcCtD
Propericiazine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00388	0.0056	CcSEcCtD
Propericiazine—ADRA1B—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00383	0.0147	CbGpPWpGaD
Propericiazine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00382	0.00552	CcSEcCtD
Propericiazine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00381	0.0055	CcSEcCtD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00378	0.0144	CbGpPWpGaD
Propericiazine—ADRA1B—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00373	0.0143	CbGpPWpGaD
Propericiazine—Constipation—Lisinopril—dilated cardiomyopathy	0.00367	0.00529	CcSEcCtD
Propericiazine—Vomiting—Furosemide—dilated cardiomyopathy	0.00363	0.00524	CcSEcCtD
Propericiazine—Rash—Furosemide—dilated cardiomyopathy	0.0036	0.0052	CcSEcCtD
Propericiazine—Dermatitis—Furosemide—dilated cardiomyopathy	0.0036	0.00519	CcSEcCtD
Propericiazine—ADRA2A—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0034	0.013	CbGpPWpGaD
Propericiazine—Nausea—Furosemide—dilated cardiomyopathy	0.00339	0.0049	CcSEcCtD
Propericiazine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00339	0.00489	CcSEcCtD
Propericiazine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00316	0.00456	CcSEcCtD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00309	0.0118	CbGpPWpGaD
Propericiazine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00293	0.00423	CcSEcCtD
Propericiazine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00273	0.00393	CcSEcCtD
Propericiazine—Rash—Lisinopril—dilated cardiomyopathy	0.0027	0.0039	CcSEcCtD
Propericiazine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.0027	0.0039	CcSEcCtD
Propericiazine—DRD1—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.00257	0.0098	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00255	0.00975	CbGpPWpGaD
Propericiazine—Nausea—Lisinopril—dilated cardiomyopathy	0.00255	0.00368	CcSEcCtD
Propericiazine—ADRA1B—AMPK Signaling—RPS6KB1—dilated cardiomyopathy	0.00234	0.00893	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.00231	0.00882	CbGpPWpGaD
Propericiazine—ADRA1B—LPA receptor mediated events—RAC1—dilated cardiomyopathy	0.00224	0.00857	CbGpPWpGaD
Propericiazine—DRD1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.00208	0.00794	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.002	0.00765	CbGpPWpGaD
Propericiazine—ADRA1B—G alpha (12/13) signalling events—RAC1—dilated cardiomyopathy	0.00198	0.00755	CbGpPWpGaD
Propericiazine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00181	0.00693	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.0017	0.00651	CbGpPWpGaD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00159	0.00606	CbGpPWpGaD
Propericiazine—ADRA1B—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.0015	0.00572	CbGpPWpGaD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00147	0.00563	CbGpPWpGaD
Propericiazine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00147	0.00562	CbGpPWpGaD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00143	0.00546	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00136	0.00519	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00136	0.00519	CbGpPWpGaD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0013	0.00496	CbGpPWpGaD
Propericiazine—ADRA1B—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00129	0.00494	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00126	0.00483	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00122	0.00467	CbGpPWpGaD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00122	0.00466	CbGpPWpGaD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00121	0.00461	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TTN—dilated cardiomyopathy	0.00119	0.00455	CbGpPWpGaD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00117	0.00447	CbGpPWpGaD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00116	0.00442	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00116	0.00442	CbGpPWpGaD
Propericiazine—ADRA2A—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00115	0.00441	CbGpPWpGaD
Propericiazine—ADRA2A—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00115	0.00441	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00112	0.00427	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00111	0.00425	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00111	0.00425	CbGpPWpGaD
Propericiazine—ADRA2A—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00107	0.0041	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00107	0.0041	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00104	0.00399	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00103	0.00395	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00103	0.00395	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00103	0.00395	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—ACTN2—dilated cardiomyopathy	0.00103	0.00394	CbGpPWpGaD
Propericiazine—ADRA1B—LPA receptor mediated events—EGFR—dilated cardiomyopathy	0.00102	0.0039	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.001	0.00383	CbGpPWpGaD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000998	0.00382	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000996	0.00381	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000991	0.00379	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000965	0.00369	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000962	0.00368	CbGpPWpGaD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000947	0.00362	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000931	0.00356	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000918	0.00351	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000918	0.00351	CbGpPWpGaD
Propericiazine—ADRA1B—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000909	0.00347	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—VCL—dilated cardiomyopathy	0.000877	0.00335	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000855	0.00327	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000853	0.00326	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000847	0.00324	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000847	0.00324	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000827	0.00316	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000824	0.00315	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000813	0.00311	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000811	0.0031	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000795	0.00304	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000787	0.00301	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000782	0.00299	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000763	0.00292	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000755	0.00288	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000735	0.00281	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000729	0.00279	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000706	0.0027	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000699	0.00267	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000699	0.00267	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000687	0.00263	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ANKRD1—dilated cardiomyopathy	0.000677	0.00259	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00067	0.00256	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000651	0.00249	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00065	0.00248	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—TAZ—dilated cardiomyopathy	0.000637	0.00243	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000629	0.00241	CbGpPWpGaD
Propericiazine—ADRA2A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000625	0.00239	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000618	0.00236	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000602	0.0023	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000585	0.00223	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000585	0.00223	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—SDHA—dilated cardiomyopathy	0.000576	0.0022	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000564	0.00216	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00056	0.00214	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000543	0.00208	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000538	0.00205	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000531	0.00203	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000531	0.00203	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000526	0.00201	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00051	0.00195	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000497	0.0019	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000493	0.00189	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000479	0.00183	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000479	0.00183	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000478	0.00183	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000458	0.00175	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000455	0.00174	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000449	0.00172	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000445	0.0017	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	0.00044	0.00168	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000435	0.00166	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000435	0.00166	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000431	0.00165	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000426	0.00163	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000408	0.00156	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000404	0.00154	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000395	0.00151	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000395	0.00151	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000391	0.0015	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000387	0.00148	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000387	0.00148	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000378	0.00145	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	0.000376	0.00144	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000368	0.00141	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000367	0.0014	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000359	0.00137	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000359	0.00137	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000356	0.00136	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	0.000354	0.00135	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000353	0.00135	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000349	0.00133	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000334	0.00128	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000334	0.00127	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000331	0.00127	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000323	0.00123	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000317	0.00121	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000316	0.00121	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000314	0.0012	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000314	0.0012	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000304	0.00116	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000301	0.00115	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000292	0.00111	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000289	0.00111	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000288	0.0011	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000287	0.0011	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000282	0.00108	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000276	0.00105	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000271	0.00104	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000262	0.001	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000259	0.00099	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000257	0.000982	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000257	0.000982	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000246	0.000941	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000241	0.000922	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000239	0.000912	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000239	0.000912	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000235	0.000899	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	0.000235	0.000897	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000231	0.000884	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000229	0.000874	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000224	0.000855	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000214	0.000817	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000212	0.00081	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000212	0.00081	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000203	0.000777	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000199	0.000762	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000197	0.000755	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000197	0.000753	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000197	0.000751	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000194	0.000742	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000191	0.000729	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000187	0.000716	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000178	0.000679	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	0.00017	0.000649	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000163	0.000624	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000163	0.000623	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000161	0.000615	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	0.000156	0.000598	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000155	0.000591	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	0.000152	0.000582	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000145	0.000556	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000139	0.000531	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	0.000137	0.000524	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000137	0.000522	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000135	0.000515	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000133	0.000508	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00012	0.000459	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000118	0.00045	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000115	0.000438	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000112	0.000428	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	9.64e-05	0.000369	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.24e-05	0.000353	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	8.08e-05	0.000309	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	7.96e-05	0.000304	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	6.61e-05	0.000253	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	5.46e-05	0.000209	CbGpPWpGaD
